Cardio Diagnostics unveils genetic–epigenetic test data for diagnosing CHD
The published data validated the AI-guided integrated genetic-epigenetic test PrecisionCHD for detecting coronary heart disease.
21 November 2023
21 November 2023
The published data validated the AI-guided integrated genetic-epigenetic test PrecisionCHD for detecting coronary heart disease.
UDX will carry out a study with 15,000 patients across 100 investigator sites to gather clinical evidence for the test.
Powerful Medical cardio’s AI powered clinical assistant outperforms doctors when diagnosing heart attacks.
The software utilises lower MRI protocols and delivers results within minutes.
Agilent Technologies has received a licence for the commercial development of the blood cancer test.
The licences will enable HeartSciences to access a collection of AI-driven ECG algorithms.
Data wirelessly collected from the pill inside the stomach demonstrated it can accurately detect respiration and cardiac rate.
Wegovy has made headlines recently in the UK, highlighting both its seismic impact and changes in health habits.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation, which has improved efficiencies and enhanced patient outcomes. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns.
Give your business an edge with our leading industry insights.